ArticleCancer control : journal of the Moffitt Cancer Center

Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis.

Ahmad Adel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.